Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Nov 1;98(9):2086–2093. doi: 10.1172/JCI119014

The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Québec Family Study and Swedish Obese Subjects cohorts.

J Gagnon 1, P Mauriège 1, S Roy 1, D Sjöström 1, Y C Chagnon 1, F T Dionne 1, J M Oppert 1, L Pérusse 1, L Sjöström 1, C Bouchard 1
PMCID: PMC507653  PMID: 8903328

Abstract

The beta adrenergic system plays a key role in regulating energy balance through the stimulation of both thermogenesis and lipid mobilization in brown and white adipose tissues in human and various animal models. Recent studies have suggested that a missense Trp64Arg mutation in the beta3 adrenergic receptor (ADRB3) gene was involved in obesity and insulin resistance. We have investigated the effect of this mutation on obesity-related phenotypes in two cohorts: the Québec Family Study (QFS) and the Swedish Obese Subjects (SOS). In QFS, no association was found between this mutation and body mass index (BMI), body fat including abdominal visceral fat, resting metabolic rate, various diabetes and cardiovascular risk factors, and changes in body weight and body fat over a 12-yr period. With the exception of RMR (P = 0.04), no evidence of linkage was detected between the mutation and phenotypes of QFS based on sib-pair data. In SOS, the frequency of the Trp64Arg allele was not significantly different between nonobese and obese female subjects and no association was found between the mutation and body weight gain over time. These findings do not support the view that there is an association between the Trp64Arg mutation in the ADRB3 gene and obesity.

Full Text

The Full Text of this article is available as a PDF (267.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amos C. I., Elston R. C., Wilson A. F., Bailey-Wilson J. E. A more powerful robust sib-pair test of linkage for quantitative traits. Genet Epidemiol. 1989;6(3):435–449. doi: 10.1002/gepi.1370060306. [DOI] [PubMed] [Google Scholar]
  2. Arch J. R., Kaumann A. J. Beta 3 and atypical beta-adrenoceptors. Med Res Rev. 1993 Nov;13(6):663–729. doi: 10.1002/med.2610130604. [DOI] [PubMed] [Google Scholar]
  3. Barbe P., Millet L., Galitzky J., Lafontan M., Berlan M. In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br J Pharmacol. 1996 Mar;117(5):907–913. doi: 10.1111/j.1476-5381.1996.tb15279.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Benson D. A., Boguski M., Lipman D. J., Ostell J. GenBank. Nucleic Acids Res. 1994 Sep;22(17):3441–3444. doi: 10.1093/nar/22.17.3441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bouchard C., Pérusse L. Genetics of obesity. Annu Rev Nutr. 1993;13:337–354. doi: 10.1146/annurev.nu.13.070193.002005. [DOI] [PubMed] [Google Scholar]
  6. Bousquet-Mélou A., Galitzky J., Lafontan M., Berlan M. Control of lipolysis in intra-abdominal fat cells of nonhuman primates: comparison with humans. J Lipid Res. 1995 Mar;36(3):451–461. [PubMed] [Google Scholar]
  7. Clément K., Vaisse C., Manning B. S., Basdevant A., Guy-Grand B., Ruiz J., Silver K. D., Shuldiner A. R., Froguel P., Strosberg A. D. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med. 1995 Aug 10;333(6):352–354. doi: 10.1056/NEJM199508103330605. [DOI] [PubMed] [Google Scholar]
  8. Desbuquois B., Aurbach G. D. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab. 1971 Nov;33(5):732–738. doi: 10.1210/jcem-33-5-732. [DOI] [PubMed] [Google Scholar]
  9. Emorine L. J., Marullo S., Briend-Sutren M. M., Patey G., Tate K., Delavier-Klutchko C., Strosberg A. D. Molecular characterization of the human beta 3-adrenergic receptor. Science. 1989 Sep 8;245(4922):1118–1121. doi: 10.1126/science.2570461. [DOI] [PubMed] [Google Scholar]
  10. Emorine L., Blin N., Strosberg A. D. The human beta 3-adrenoceptor: the search for a physiological function. Trends Pharmacol Sci. 1994 Jan;15(1):3–7. doi: 10.1016/0165-6147(94)90118-x. [DOI] [PubMed] [Google Scholar]
  11. Enocksson S., Shimizu M., Lönnqvist F., Nordenström J., Arner P. Demonstration of an in vivo functional beta 3-adrenoceptor in man. J Clin Invest. 1995 May;95(5):2239–2245. doi: 10.1172/JCI117914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ferland M., Després J. P., Tremblay A., Pinault S., Nadeau A., Moorjani S., Lupien P. J., Thériault G., Bouchard C. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br J Nutr. 1989 Mar;61(2):139–148. doi: 10.1079/bjn19890104. [DOI] [PubMed] [Google Scholar]
  13. Granneman J. G., Lahners K. N., Chaudhry A. Characterization of the human beta 3-adrenergic receptor gene. Mol Pharmacol. 1993 Aug;44(2):264–270. [PubMed] [Google Scholar]
  14. Granneman J. G., Lahners K. N., Chaudhry A. Molecular cloning and expression of the rat beta 3-adrenergic receptor. Mol Pharmacol. 1991 Dec;40(6):895–899. [PubMed] [Google Scholar]
  15. Haseman J. K., Elston R. C. The investigation of linkage between a quantitative trait and a marker locus. Behav Genet. 1972 Mar;2(1):3–19. doi: 10.1007/BF01066731. [DOI] [PubMed] [Google Scholar]
  16. Hoffstedt J., Shimizu M., Sjöstedt S., Lönnqvist F. Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells. Obes Res. 1995 Sep;3(5):447–457. doi: 10.1002/j.1550-8528.1995.tb00174.x. [DOI] [PubMed] [Google Scholar]
  17. Kadowaki H., Yasuda K., Iwamoto K., Otabe S., Shimokawa K., Silver K., Walston J., Yoshinaga H., Kosaka K., Yamada N. A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun. 1995 Oct 13;215(2):555–560. doi: 10.1006/bbrc.1995.2500. [DOI] [PubMed] [Google Scholar]
  18. Krief S., Lönnqvist F., Raimbault S., Baude B., Van Spronsen A., Arner P., Strosberg A. D., Ricquier D., Emorine L. J. Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest. 1993 Jan;91(1):344–349. doi: 10.1172/JCI116191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lafontan M., Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res. 1993 Jul;34(7):1057–1091. [PubMed] [Google Scholar]
  20. Langin D., Portillo M. P., Saulnier-Blache J. S., Lafontan M. Coexistence of three beta-adrenoceptor subtypes in white fat cells of various mammalian species. Eur J Pharmacol. 1991 Jul 9;199(3):291–301. doi: 10.1016/0014-2999(91)90492-9. [DOI] [PubMed] [Google Scholar]
  21. Lelias J. M., Kaghad M., Rodriguez M., Chalon P., Bonnin J., Dupre I., Delpech B., Bensaid M., LeFur G., Ferrara P. Molecular cloning of a human beta 3-adrenergic receptor cDNA. FEBS Lett. 1993 Jun 14;324(2):127–130. doi: 10.1016/0014-5793(93)81377-c. [DOI] [PubMed] [Google Scholar]
  22. Li L. S., Lönnqvist F., Luthman H., Arner P. Phenotypic characterization of the Trp64Arg polymorphism in the beta 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia. 1996 Jul;39(7):857–860. doi: 10.1007/s001250050521. [DOI] [PubMed] [Google Scholar]
  23. Lissner L., Sjöström L., Bengtsson C., Bouchard C., Larsson B. The natural history of obesity in an obese population and associations with metabolic aberrations. Int J Obes Relat Metab Disord. 1994 Jun;18(6):441–447. [PubMed] [Google Scholar]
  24. Lönnqvist F., Krief S., Strosberg A. D., Nyberg S., Emorine L. J., Arner P. Evidence for a functional beta 3-adrenoceptor in man. Br J Pharmacol. 1993 Nov;110(3):929–936. doi: 10.1111/j.1476-5381.1993.tb13902.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lönnqvist F., Thöme A., Nilsell K., Hoffstedt J., Arner P. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. J Clin Invest. 1995 Mar;95(3):1109–1116. doi: 10.1172/JCI117758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mahmoudian M. The complex of human Gs protein with the beta 3 adrenergic receptor: a computer-aided molecular modeling study. J Mol Graph. 1994 Mar;12(1):22-8, 34. doi: 10.1016/0263-7855(94)80004-9. [DOI] [PubMed] [Google Scholar]
  27. Mauriège P., Marette A., Atgié C., Bouchard C., Thériault G., Bukowiecki L. K., Marceau P., Biron S., Nadeau A., Després J. P. Regional variation in adipose tissue metabolism of severely obese premenopausal women. J Lipid Res. 1995 Apr;36(4):672–684. [PubMed] [Google Scholar]
  28. Meneely G. R., Kaltreider N. L. THE VOLUME OF THE LUNG DETERMINED BY HELIUM DILUTION. DESCRIPTION OF THE METHOD AND COMPARISON WITH OTHER PROCEDURES. J Clin Invest. 1949 Jan;28(1):129–139. doi: 10.1172/JCI102041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Muzzin P., Revelli J. P., Kuhne F., Gocayne J. D., McCombie W. R., Venter J. C., Giacobino J. P., Fraser C. M. An adipose tissue-specific beta-adrenergic receptor. Molecular cloning and down-regulation in obesity. J Biol Chem. 1991 Dec 15;266(35):24053–24058. [PubMed] [Google Scholar]
  30. Nahmias C., Blin N., Elalouf J. M., Mattei M. G., Strosberg A. D., Emorine L. J. Molecular characterization of the mouse beta 3-adrenergic receptor: relationship with the atypical receptor of adipocytes. EMBO J. 1991 Dec;10(12):3721–3727. doi: 10.1002/j.1460-2075.1991.tb04940.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Oppert J. M., Nadeau A., Tremblay A., Després J. P., Thériault G., Dériaz O., Bouchard C. Plasma glucose, insulin, and glucagon before and after long-term overfeeding in identical twins. Metabolism. 1995 Jan;44(1):96–105. doi: 10.1016/0026-0495(95)90295-3. [DOI] [PubMed] [Google Scholar]
  32. Oppert J. M., Vohl M. C., Chagnon M., Dionne F. T., Cassard-Doulcier A. M., Ricquier D., Pérusse L., Bouchard C. DNA polymorphism in the uncoupling protein (UCP) gene and human body fat. Int J Obes Relat Metab Disord. 1994 Aug;18(8):526–531. [PubMed] [Google Scholar]
  33. Piétri-Rouxel F., Lenzen G., Kapoor A., Drumare M. F., Archimbault P., Strosberg A. D., Manning B. S. Molecular cloning and pharmacological characterization of the bovine beta 3-adrenergic receptor. Eur J Biochem. 1995 May 15;230(1):350–358. [PubMed] [Google Scholar]
  34. Ravussin E., Lillioja S., Knowler W. C., Christin L., Freymond D., Abbott W. G., Boyce V., Howard B. V., Bogardus C. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med. 1988 Feb 25;318(8):467–472. doi: 10.1056/NEJM198802253180802. [DOI] [PubMed] [Google Scholar]
  35. Richterich R., Dauwalder H. Zur Bestimmung der Plasmaglucosekonzentration mit der Hexokinase-Glucose-6-Phosphat-Dehydrogenase-Methode. Schweiz Med Wochenschr. 1971 May 1;101(17):615–618. [PubMed] [Google Scholar]
  36. Rosenbaum M., Malbon C. C., Hirsch J., Leibel R. L. Lack of beta 3-adrenergic effect on lipolysis in human subcutaneous adipose tissue. J Clin Endocrinol Metab. 1993 Aug;77(2):352–355. doi: 10.1210/jcem.77.2.8393882. [DOI] [PubMed] [Google Scholar]
  37. SIRI W. E. The gross composition of the body. Adv Biol Med Phys. 1956;4:239–280. doi: 10.1016/b978-1-4832-3110-5.50011-x. [DOI] [PubMed] [Google Scholar]
  38. Sjöström L., Larsson B., Backman L., Bengtsson C., Bouchard C., Dahlgren S., Hallgren P., Jonsson E., Karlsson J., Lapidus L. Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord. 1992 Jun;16(6):465–479. [PubMed] [Google Scholar]
  39. Strosberg A. D. Structure, function, and regulation of the three beta-adrenergic receptors. Obes Res. 1995 Nov;3 (Suppl 4):501S–505S. doi: 10.1002/j.1550-8528.1995.tb00219.x. [DOI] [PubMed] [Google Scholar]
  40. Susulic V. S., Frederich R. C., Lawitts J., Tozzo E., Kahn B. B., Harper M. E., Himms-Hagen J., Flier J. S., Lowell B. B. Targeted disruption of the beta 3-adrenergic receptor gene. J Biol Chem. 1995 Dec 8;270(49):29483–29492. doi: 10.1074/jbc.270.49.29483. [DOI] [PubMed] [Google Scholar]
  41. Tavernier G., Barbe P., Galitzky J., Berlan M., Caput D., Lafontan M., Langin D. Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. J Lipid Res. 1996 Jan;37(1):87–97. [PubMed] [Google Scholar]
  42. Walston J., Silver K., Bogardus C., Knowler W. C., Celi F. S., Austin S., Manning B., Strosberg A. D., Stern M. P., Raben N. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med. 1995 Aug 10;333(6):343–347. doi: 10.1056/NEJM199508103330603. [DOI] [PubMed] [Google Scholar]
  43. Widén E., Lehto M., Kanninen T., Walston J., Shuldiner A. R., Groop L. C. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med. 1995 Aug 10;333(6):348–351. doi: 10.1056/NEJM199508103330604. [DOI] [PubMed] [Google Scholar]
  44. Yoshida T., Sakane N., Umekawa T., Sakai M., Takahashi T., Kondo M. Mutation of beta 3-adrenergic-receptor gene and response to treatment of obesity. Lancet. 1995 Nov 25;346(8987):1433–1434. doi: 10.1016/s0140-6736(95)92452-3. [DOI] [PubMed] [Google Scholar]
  45. Zaagsma J., Nahorski S. R. Is the adipocyte beta-adrenoceptor a prototype for the recently cloned atypical 'beta 3-adrenoceptor'? Trends Pharmacol Sci. 1990 Jan;11(1):3–7. doi: 10.1016/0165-6147(90)90032-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES